期刊文献+

国内外血站分离血浆利用概况 被引量:9

Reviews on recovered plasma from non-remunerated whole blood donation system in China and abroad
下载PDF
导出
摘要 目前我国血液制品生产用原料血浆严重紧缺,而血站富余分离血浆无法进行再利用而面临报废的困境,宝贵的血液资源未能得到有效的综合利用。而很多国家和地区均采用自行加工或委托加工等方式将血站分离血浆用于血液制品生产。本文总结了国内外血站分离血浆的利用概况,可对我国血站富余分离血浆在满足临床需求的前提下用于血液制品生产提供参考。 Continuous shortage of source plasma for fractionation has historically been a major obstacle to reach national self-sufficiency of plasma products in China. On the other hand, the recovered plasma generated from non-remunerated whole blood donations has been facing challenges of being discardea as useless products, leading to wastage of valuable blood resources. This article reviews the current situation and perspectives of recovered plasma utilizations in developed countries, in order to raise awareness of the role of recovered plasma as a starting material supplement for fractionation in meeting clinical needs in China.
出处 《中国输血杂志》 CAS CSCD 北大核心 2014年第10期1068-1071,共4页 Chinese Journal of Blood Transfusion
关键词 分离血浆 原料血浆 血站 血液制品生产 recovered plasma source plasma blood bank plasma fractionation
  • 相关文献

参考文献23

  • 1FDA. Code of federal regulations,Title 21, Volume 7,2013 : [ 2014- 4-5 ] http://www, fda. gov/medicaldevices/deviceregulationand- guidance/databases/ucm135680, htm.
  • 2Commonwealth of Australia. Review of Australia's plasma fractiona- tion arrangements, 2006: [ 2014-4-5 ]. http ://www. health, gov. au/plasmafractionationreview.
  • 3WHO. Recommendations for the production, control and regulation of human plasma for fractionation, the 56th meeting of the WHO Expert Committee on Biological Standardization, 2005 : [ 2014-4- 5 ]. http ://www. who. int/blood products.
  • 4United States General Accounting Office. Plasma product risks are low if good manufacturing practices are followed, 1998: [ 2014-4- 5 ]. http ://www. gao. gov.
  • 5Van der Pol CL, Seifried E, and Schaasberg WP, Paying for blood donations t still a risk ? Vox Sang,2002,83 (4) :285-293.
  • 6Engelfriet CP, Reesink HW, Farrugia A, et al. International Forum, ' Paid vs. unpaid donors', Vox Sang,2006,90( 1) :63-70.
  • 7MRB, International directory of plasma fractionators, 2008 : [ 2014- 4 -5 ]. http ://marketingresearchbureau. corn.
  • 8WHO. Towards self-sufficiency in safe blood and blood products based on voluntary non-remunerated donation, Global Status 2013, 2013 : [ 2014-4-5 ]. http ://www. who. int/bloodsafety/global_data- base/on/.
  • 9AABB. Issue summary, Blood products advisory Committee 100th Meeting, 2011 : [ 2014-4-5 ]. https ://www. aabb. org/events/gov- emment/bpac/Pages/bpackmeetin42811, aspx.
  • 10Robert P. Worldwide supply and demand of plasma and plasma- de- rived medicines. Iranian Journal of Blood and Cancer, 2011,3 (3) : 111-120.

共引文献24

同被引文献91

  • 1王迅.核酸检测技术(NAT)及其在血液筛检中的应用[J].中国输血杂志,2004,17(6):465-468. 被引量:30
  • 2国家食品药品监督管理局.药品注册管理办法(局令第28号).2007-07-10.
  • 3章昊,马兰,叶贤林.深圳市无偿献血者输血相关传染病标志物检测结果分析[J].中国现代医学杂志,2007,17(22):2796-2798. 被引量:15
  • 4AABB.Issue Summary.Washington DC:Blood Products Advisory Committee 100th Meeting.2011-04-29[2014-03-15]https://www.aabb.org/events/government/bpac/Pages/bpackmeeting042811.aspx.
  • 5Office of the Federal Register National Archives and Records Administration.Food and drugs,Parts 600 to 799,/FDA.Code of federal regulations,Vol 7.2013-04-01[2014-03-15]http://www.fda.gov/medicaldevices/deviceregulationandguidance/databases/ucm135680.htm.
  • 6Philip Flood AO,Peter Wills AC.et al.Review of Australia's plasma fractionation arrangements ISBN:1741861217,2006:[2014-3-15].http://www.health.gov.au/plasmafractionationreview.
  • 7WHO.Recommendations for the production,control and regulation of human plasma for fractionation,the 56th meeting of the WHO Expert Committee on Biological Standardization,2005-10-24[2014-3-15]http://www.who.int/blood products.
  • 8FDA,CPG Sec.230.100,Blood and blood products-definitions,2009.[2014-03-15]http://www.fda.gov/iceci/compliancemanuals/compliancepolicyguidancemanual/ucm073861.htm.
  • 9AABB,ABC,ARC,et al.Proposal to FDA on recovered plasma.2003-06-06[2014-03-15].http://www.aabb.org/pressroom/comments/Pages/recplasbpac062003.aspx.
  • 10AABB.Issue Summary.Washington:Blood Products Advisory Committee 102nd Meeting,2012-05-16:[2014-3-15].https://www.aabb.org/events/government/bpac/Pages/bpacmeeting051512.aspx.

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部